Recent Blog Posts
New Jersey and New York Patent Attorneys Serving Clients Nationwide If an inventor wants to patent selling two or more…
On Monday, June 24, 2019, the U.S. Supreme Court in a 6-3 ruling, struck down a provision of federal law…
Court have held that Section 43(a) of the Lanham Act entitles celebrities to sue for trademark infringement when others use…
We believe that the proposed amendment fixes most of the problems battled by the courts, the USPTO and the patent…
A lawsuit that managed to make it all the way to the SCOTUS (Supreme Court of the United States) involves…
The House subcommittee on intellectual property convened a meeting to oversee the U.S. Patent and Trademark Office. Among two of…
The Federal Circuit recently vacated a district court decision which found a patent for the antipsychotic drug “Saphris,” belonging to Forest Laboratories (Forest), valid as nonobvious, but not infringed by ANDA filers Alembic Pharmaceuticals Ltd. (Ale…
Today, April 3, the Senate Subcommittee on Intellectual Property held a hearing titled Trailblazers and Lost Einsteins: Women Inventors and the Future of American Innovation—a topic that also was considered last Wednesday by the House Committee on the …
In ChargePoint Inc. v. SemaConnect, Inc., (2018-1739) the Federal Circuit inexplicably stated in its opinion that “[i]t is clear from the language of claim 1 that the claim involves an abstract idea—namely, the abstract idea of communicating requests t…
On March 8, Foster Pepper filed a petition for certiorari with the Supreme Court, case number 18-1199, challenging the Federal Circuit’s emerging “physical realm” test as part of its Alice/Section 101 analysis. Amicus briefs in support of our cert peti…
In one of its latest opinions attempting to parse precedent on the subject matter eligibility of software, method of use, and business method patents that arguably involve application of laws of nature or recitations of well-known, conventional methods…